Dev Patel, “Role of Proprotein Convertase Subtilisin Kexin Type 9 Inhibitor Therapy in treatment of Patients with Polycystic Ovary Syndrome: A systemic Review of Metabolic and Cardiovascular Outcomes ”, Journal For International Medical Graduates , vol. 3, no. 1, Feb. 2024, doi: 10.56570/jimgs.v1i1.149.